A coordinated two-week operation between ICE and multiple West Virginia law enforcement agencies has resulted in the arrest of more than 650 individuals for immigration violations, including some with criminal histories.
A fatal bus crash in southern Turkey's Antalya province has claimed nine lives and injured 26 others, with authorities citing wet roads, fog, and suspected speeding as contributing factors in the Sunday morning tragedy.
Christie Oster, a recently honored middle school educator in Lafayette Parish, faces serious felony charges following allegations of an inappropriate relationship with a former student, casting a shadow over her celebrated career.
Glaukos Corporation's iDose TR glaucoma therapy receives a key FDA labeling update, permitting repeat administration. While the news bolsters the company's growth narrative, analysts are divided on whether its current stock price already reflects future potential amid rich valuation metrics.
With shares of the global sustainability leader up nearly 7x over three years, investors are grappling with a critical question: has the market run too far ahead of fundamentals? A deep dive into valuation metrics suggests caution may be warranted.
Idorsia's exclusive licensing agreement with EMS to commercialize insomnia drug QUVIVIQ across Latin America marks a key step in its global expansion. The deal, involving $20 million in milestones and royalties, arrives as long-term data for its Fabry disease candidate lucerastat puts the spotlight on the company's broader late-stage pipeline and persistent financial pressures.
As China's pork industry grapples with overcapacity and falling prices, a growing appetite for premium, flavorful black pork among the middle class is offering a lifeline to farmers and reshaping market strategies.
The FDA's approval of a repeat treatment protocol for Glaukos's iDose TR implant transforms it from a one-time procedure into a potential chronic therapy platform, reshaping its commercial narrative and investor calculus in the competitive glaucoma market.
With shares languishing near $5.74, Bausch Health Companies (BHC) presents a stark valuation puzzle. While a standard DCF model suggests a staggering 91% undervaluation, the market's persistent sell-off reflects deep-seated concerns over the company's restructuring path and debt burden. We examine the numbers behind the divergence.
Despite a sharp 22% drop in cocoa sales volume and multi-year lows in cocoa futures, Barry Callebaut's (SWX:BARN) share price has rallied strongly. Analysts are divided on whether the current valuation reflects deep value or overlooks persistent headwinds in its core commodity business.
Despite a stellar 38% gain over the past year, analysis suggests Federated Hermes (NYSE: FHI) shares may still be trading at a discount to their intrinsic value, presenting a potential opportunity in the capital markets sector.
Tilray Brands deepens its commitment to Europe's regulated medical cannabis sector with the launch of Tilray Medical Italia, a strategic venture with local partner Molteni Farmaceutici. The move comes as the company seeks to stabilize its growth narrative amid significant stock market volatility.
USA Rare Earth secures a landmark $1.6 billion in federal loans and equity, coupled with a $1.5 billion private placement, to build a domestic supply chain from Texas mines to Oklahoma magnets, reducing reliance on China for critical defense and green tech components.
Shares of Verizon Communications surged nearly 12% on Friday, marking their third consecutive day of gains, after the telecom giant posted solid annual results and unveiled aggressive growth targets for its core wireless and broadband businesses.
Boeing's Wichita-based engineering union has overwhelmingly approved a new labor agreement, securing substantial pay raises and improved benefits for approximately 1,600 technical staff, many recently transitioned from Spirit AeroSystems.
Norwegian Cruise Line Holdings (NCLH) reported robust annual revenue of $9.69 billion and net income of $663.5 million, reigniting investor interest. However, the stock's recent volatility and a significant one-year decline in total shareholder return have sparked a debate over whether the current share price accurately reflects the company's recovery trajectory and future prospects.
Amcor's shares have rallied over 6% in the past month, sparking debate among investors. While a discounted cash flow model suggests significant undervaluation, its elevated P/E ratio tells a conflicting story. We examine the metrics and the broader packaging sector's challenges to assess the opportunity.
A devastating landslide at the Rubaya coltan mine in eastern DRC has claimed hundreds of lives, casting a harsh spotlight on the perilous conditions in artisanal mining and the complex conflict over the region's critical minerals.
Amid soaring valuations and bubble fears, venture capital heavyweight Ben Horowitz argues the AI surge is fundamentally different, driven by historic customer adoption and revenue growth that signals a new computing era.
As tech volatility reshuffles investor priorities in early 2026, a screen for strength and analyst conviction highlights three dividend payers—from lithium to offshore drilling—that are already setting the pace.
